Markup of Markup of H.R. 4299, Improving Regulatory Transparency for New Medical Therapies Act; H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act; and, H.R. 4631, Combating Autism Reauthorization Act of 2014

Subcommittee on Health (Committee on Energy and Commerce)

Wednesday, May 28, 2014 (2:00 PM)

2123 RHOB
Washington, D.C.

Text of Legislation

  • H.R. 4299, Improving Regulatory Transparency for New Medical Therapies Act [PDF]
  • H.R. 4631, Combating Autism Reauthorization Act of 2014 [PDF]
  • H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act [PDF] Added 05/28/2014 at 09:01 AM

Amendments

  • Amendment in the Nature of a Substitute to H.R. 4631 [PDF] Added 05/28/2014 at 10:37 AM

Support Documents

  • Markup Notice [PDF]
  • Markup Memo [PDF]
  • Opening Statement of Subcommittee Chairman Pitts [PDF] Added 05/28/2014 at 09:28 AM
  • Opening Statement of Committee Chairman Upton [PDF] Added 05/28/2014 at 02:58 PM
  • Document for the Record, Epilepsy Foundation [PDF] Added 05/28/2014 at 02:58 PM
  • Document for the Record, APAM [PDF] Added 05/28/2014 at 02:58 PM
  • Document for the Record, NACDS [PDF] Added 05/28/2014 at 02:58 PM
  • Document for the Record, HCPA [PDF] Added 05/28/2014 at 02:58 PM
  • Document for the Record, HDMA [PDF] Added 05/28/2014 at 02:58 PM
  • Attendance [PDF] Added 05/28/2014 at 02:58 PM
  • Markup transcript [PDF] Added 06/17/2014 at 10:51 AM
  • Opening Statement of Ranking Member Waxman [PDF] Added 07/09/2014 at 11:22 AM

First Published: May 23, 2014 at 12:41 PM
Last Updated: July 9, 2014 at 11:22 AM